Best Stocks To Buy: Brokerage firm Nomura has recommended buying shares of Sun Pharmaceutical Industries, the country's largest pharmaceutical company. The brokerage firm is confident, considering the company's strong performance in the third quarter of the current financial year. In the December quarter, the company's net profit increased by 15% year-on-year to ₹2,903.3 crore, and operating income increased by 10.5% to ₹13,675.4 crore. The brokerage firm has set a long-term target price of ₹1,970 for this stock. On March 11, the stock closed at ₹1,657, up 2.82%.